The ASCO-CAP FISH group 4 (HER2-equivocal) and ASCO-CAP FISH group 5 (HER2-negative) breast cancers included in this study were associated with low levels of HER2 protein expression by immunohistochemical analysis (eTable 2 in the Supplement). Here, ERBB2 is linked to breast cancer.